戻る
Axim Biotechnologies Inc (AXIM)価格
AXIM 株価推移チャート
AXIM 収入
Axim Biotechnologies Inc
$0.01
19.83%
$0
終値： Feb 06, 16:00:00 GMT-5
$0.01
0%
$0
アフターマーケット：Feb 06, 20:00:00 GMT-5
Earnings FAQ
AXIMの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Axim Biotechnologies Inc AXIMの前四半期の収益はどうでしたか？
Axim Biotechnologies Incの収益見積もりはいくらですか？
Axim Biotechnologies Incの収益品質スコアはどれくらいですか？
Axim Biotechnologies Incはいつ収益を報告しますか？
Axim Biotechnologies Incの予想収益はいくらですか？
Axim Biotechnologies Incは収益予想を上回りましたか？
主要データ
前終値
$0.0121
始値
$0.013
当日レンジ
$0.013 - $0.0145
52週レンジ
$0.003 - $0.029
取引高
136.5K
平均取引高
489.4K
1株当たり利益(TTM)
-0.02
配当利回り
--
時価総額
$4.8M
AXIMとは何ですか？
AXIM Biotechnologies, Inc. operates as a biotechnology company, which engages in the development of diagnostic healthcare solutions. The company is headquartered in San Diego, California and currently employs 6 full-time employees. The company went IPO on 2013-04-09. The firm is focused on improving the landscape for the diagnosis of ophthalmological conditions such as dry eye disease (DED) through rapid diagnostic tests. Its core competencies include development of rapid lateral flow immunoassays, reagents, and monoclonal antibody development for such assays. Its product categories include Eye Health, wherein the Company acquired two FDA cleared tests for dye eye disease and has internally developed a third assay; and SARS-CoV-2 neutralizing antibody tests. The firm is focused on developing a proprietary diagnostic platform that can be adapted to test for a variety of analytes including SARS-Cov-2, Lactoferrin, IgE, Lacritin, and MMP-9. Its platform capability can also be applied to rapid testing for vaccine candidates. Its platform can also be used to enable point-of-care detection for one or more cancers using a unique cancer biomarker, QSOX1-L.